Diagnostics & Research
The Diagnostics & Research industry has a total of 50 stocks, with a combined market cap of $778.98 billion, total revenue of $166.47 billion and a weighted average PE ratio of 52.09.
Market Cap
778.98B
Revenue
166.47B
Profits
14.96B
PE Ratio
52.09
Profit Margin
8.98%
Dividend Yield
0.18%
50 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | TMO | Thermo Fisher Scientific Inc. | 213.34B | 0.97% | 3,862,646 | 43.74B |
| 2 | DHR | Danaher Corporation | 158.82B | 0.22% | 6,318,059 | 24.27B |
| 3 | IDXX | IDEXX Laboratories, Inc. | 55.92B | 0.46% | 1,682,541 | 4.17B |
| 4 | A | Agilent Technologies, Inc. | 38.85B | 0.25% | 4,959,132 | 6.95B |
| 5 | IQV | IQVIA Holdings Inc. | 37.58B | -0.82% | 4,467,376 | 15.90B |
| 6 | NTRA | Natera, Inc. | 32.08B | 3.21% | 2,218,246 | 2.12B |
| 7 | MTD | Mettler-Toledo International Inc. | 28.65B | 0.94% | 445,195 | 3.94B |
| 8 | WAT | Waters Corporation | 22.51B | 0.46% | 1,910,722 | 3.11B |
| 9 | LH | Labcorp Holdings Inc. | 20.89B | - | 1,613,071 | 13.77B |
| 10 | ILMN | Illumina, Inc. | 20.59B | 3.27% | 5,363,142 | 4.29B |
| 11 | DGX | Quest Diagnostics Incorporated | 19.59B | -0.05% | 1,580,889 | 10.85B |
| 12 | EXAS | Exact Sciences Corporation | 19.32B | 0.43% | 6,111,124 | 3.08B |
| 13 | MEDP | Medpace Holdings, Inc. | 16.01B | 1.45% | 378,445 | 2.36B |
| 14 | ICLR | ICON Public Limited Company | 13.27B | -2.76% | 1,411,860 | 8.10B |
| 15 | GH | Guardant Health, Inc. | 12.85B | 2.72% | 3,451,704 | 902.57M |
| 16 | RVTY | Revvity, Inc. | 10.91B | -0.02% | 2,867,434 | 2.81B |
| 17 | QGEN | Qiagen N.V. | 9.88B | 1.38% | 2,214,816 | 2.07B |
| 18 | CRL | Charles River Laboratories International, Inc. | 9.70B | 1.66% | 1,174,534 | 4.02B |
| 19 | RDNT | RadNet, Inc. | 5.93B | 7.39% | 2,027,117 | 1.97B |
| 20 | SHC | Sotera Health Company | 4.88B | 0.35% | 4,537,211 | 1.15B |
| 21 | BLLN | BillionToOne, Inc. | 4.70B | 7.43% | 491,486 | 254.14M |
| 22 | WGS | GeneDx Holdings Corp. | 4.06B | 3.02% | 282,118 | 402.19M |
| 23 | GRAL | GRAIL, Inc. | 3.55B | 3.14% | 2,417,098 | 141.83M |
| 24 | VCYT | Veracyte, Inc. | 3.39B | 2.09% | 1,159,990 | 495.14M |
| 25 | TWST | Twist Bioscience Corporation | 1.99B | 1.85% | 1,541,777 | 376.57M |
| 26 | NEOG | Neogen Corporation | 1.56B | -3.61% | 3,428,922 | 886.89M |
| 27 | NEO | NeoGenomics, Inc. | 1.53B | 1.28% | 2,806,036 | 709.16M |
| 28 | CSTL | Castle Biosciences, Inc. | 1.15B | -0.40% | 361,576 | 343.53M |
| 29 | OPK | OPKO Health, Inc. | 1.01B | - | 5,716,145 | 642.07M |
| 30 | CDNA | CareDx, Inc | 1.00B | 1.35% | 1,532,624 | 358.00M |
| 31 | FLGT | Fulgent Genetics, Inc. | 853.49M | -1.60% | 348,938 | 315.55M |
| 32 | PSNL | Personalis, Inc. | 759.28M | 7.82% | 6,946,287 | 69.10M |
| 33 | MYGN | Myriad Genetics, Inc. | 610.55M | -2.24% | 3,259,616 | 825.30M |
| 34 | PRE | Prenetics Global Limited | 294.16M | 6.00% | 167,476 | 77.08M |
| 35 | BNR | Burning Rock Biotech Limited | 236.87M | 7.16% | 95,892 | 75.75M |
| 36 | MDXH | MDxHealth SA | 155.92M | -0.32% | 167,603 | 103.07M |
| 37 | IMDX | Insight Molecular Diagnostics Inc. | 155.07M | 4.24% | 118,496 | 4.40M |
| 38 | XGN | Exagen Inc. | 145.72M | -0.62% | 266,156 | 63.60M |
| 39 | FONR | FONAR Corporation | 97.42M | -1.26% | 12,536 | 105.43M |
| 40 | BDSX | Biodesix, Inc. | 53.22M | -5.77% | 203,186 | 80.17M |
| 41 | PRPO | Precipio, Inc. | 38.88M | -4.31% | 8,455 | 22.80M |
| 42 | NOTV | Inotiv, Inc. | 22.96M | 3.33% | 338,990 | 513.02M |
| 43 | MBAI | Check-Cap Ltd. | 11.00M | 5.62% | 35,314 | - |
| 44 | MYNZ | Mainz Biomed N.V. | 10.30M | -2.44% | 400,552 | 659.94K |
| 45 | ADVB | Advanced Biomed Inc. | 7.58M | 1.80% | 61,185 | - |
| 46 | NDRA | ENDRA Life Sciences Inc. | 5.72M | -3.16% | 42,014 | - |
| 47 | BIAF | bioAffinity Technologies, Inc. | 5.57M | 1.64% | 73,989 | 6.78M |
| 48 | XWEL | XWELL, Inc. | 3.78M | -7.75% | 63,254 | 29.52M |
| 49 | ISPC | iSpecimen Inc. | 3.62M | -4.59% | 211,347 | 3.35M |
| 50 | PRPH | ProPhase Labs, Inc. | 414.23K | -14.65% | 37,366,420 | 5.06M |